Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish verapamil infarction trial II - DAVIT II)

Volumn 10, Issue 66, 1990, Pages 779-785

  Hansen, Jørgen Fischer ^b   Mellemgaard, K ^a   Pedersen Bjergaard, O ^a   Rasmussen, B ^a   Launbjerg, J ^a   Fruergaard, P ^a   Eliasen, P ^a   Ronnov Jessen V ^a   Nielsen, P E ^a   Ralkiaer N ^a   Heiberg, J K ^a   Ibsen Bank, J ^a   Nielsen, H ^a   Jespersen, C ^a   Egeblad, H ^a   Vaage Nilsen, M ^a   Vesterdal Jorgensen J ^a   Carlsen, A ^c   Riisgaard Petersen, O ^c   Rasmussen, L ^c   Nielsen, I ^a   Hollander N H ^a   Mork Jorgensen L ^a   Olsen, E ^a   Lorenzen, T ^a   Christiansen, P ^a   Larsen, J ^a   Sturup H ^a   Jorgensen C ^a   Bogild Hansen S ^a   Rattleff, A ^a   Velander, B ^a   Hansen, F ^a   Budek, T ^a   Godtfredsen, J ^a   Skagen, K ^a   Feldstedt, M ^a   Aldershvile, J ^a   Boesgaard, S ^a   Garde, K ^a   Juhl, H ^a   Larsen, C Chr ^a   Mikkelsen, L ^a   Sigurd, B ^d   Grange, T ^d   Strunge, P ^a   Linde, N C ^a   Drewes, V M ^e   Ostergaard Andersen J ^e   Madsen, J I ^e   Heeger Jensen, B ^e   Albers, C ^e   Dahl, P ^e   Faber, O ^a   Orholm, M ^a   Helqvist, S ^a   Vejby Christensen, H ^a   Skjytth, P ^a   Sommer, L ^a   Albsek Jensen, P ^a   Eidner, P O ^a   Axel Gaard, G ^a   Utzon, P ^a   Hagerup, L ^a   Nielsen, J ^a   Hven, P E ^a   Drechsler, B ^a   Soltoft J ^a   Brunsgaard, N ^a   Thomsen, H ^f   Steinmetz, E ^a   Hoby Andersen, H ^a   Rud Andersen, H ^a   Fallesen, I ^a   Nielsen, D ^a   Olesen, L L ^a   Svendsen, F ^a   Jepsen, S ^a   Skaaning Laursen, J ^a   Herlevsen, P ^a   Clemmensen, K ^a   Nielsen, C ^a   Mourits Andersen, T ^a   Bynemann, L ^a   Nielsen, F ^a   Mailing, B ^a   Stentoft, J ^a   Varming, K ^a   Lindskov, Chr ^a   Jensen, I ^a   Sorensen J ^a   Agnholt, J ^a   Siersbaek M ^a   Pedersen, J ^a   Thue Jensen, J ^a   Knudsen, L ^a   Stens Pedersen, H ^a   Toft Sorensen H ^a   Toft, E ^a   Jensen, N ^a   Steensen, P ^a   Madsen, E ^a   Korsager, S ^a   Fritz Hansen, P ^a   Kjoller E ^a   Donovan, A M ^a   Spange Mortensen, L ^g   more..

^a Municipal Hospital ^*  (Denmark)

^b Center for Health and Society   (Denmark)

^c NONE   (Denmark)

^d NONE   (Denmark)

^e NONE   (Denmark)

^f NONE   (Denmark)

^g UNI C   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

VERAPAMIL;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEATH; FATALITY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SECONDARY PREVENTION;

EID: 0025052399     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Nayler WG. Calcium antagonists and the ischemic myocardium. Int J Cardiol 1987;15:267-85.
2. Kloner RA, Braunwald E. Effects of calcium antagonists on infarcting myocardium. Am J Cardiol 1987;59:84B-94B.
3. Skolnick AE, Frishman WH. Calcium channel blockers in myocardial infarction. Arch Intern Med 1989;149:1669-1677.
4. Hansen JF, Sigurd B, Mellemgaard K, Lyngbye J. Verapamil in acute myocardial infarction. Dan Med Bull 1980:27:105-109.
5. The Danish Study Group on Verapamil in Myocardial Infarction. Verapamil in acute myocardial infarction. Eur Heart J 1984:5:516-528.
6. The Danish Study Group on Verapamil in Myocardial Infarction. Verapamil in acute myocardial infarction. Am J Cardiol 1984;54:24E-28E.
7. The Danish Study Group on Verapamil in Myocardial Infarction. The Danish studies on verapamil in myocardial infarction. Br J Clin Pharmacol 1986;21:197S-204S.
8. Reimer KA, Jennings RB. Verapamil in two reperfusion models of myocardial infarction. Lab Invest 1984;51:655-666.
9. Yellon DM, Hearse J, Maxwell MP, Chambers DE, Downey JM. Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapamil infusion in dogs with small myocardial infarcts. Am J Cardiol 1983:51:14091413.
10. Przyklenk K, Kloner RA. Effect of verapamil on postischemic "stunned" myocardium. Importance of the timing of treatment. J Am Coll Cardiol 1988;11:614-623.
11. Subramanian VB, Bowles ML, Lahiri A, Davies AB, Raftcry EB. Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testing. Am J Cardiol 1981;48:529-535.
12. Mauritson DR, Johnson SM, Winniford MD, Gary JR, Willerson JT, Hillis LD. Verapamil for unstable angina at rest. A short-termed randomized, double blind study. Am Heart J 1983;106:652-658.
13. Mauri F, Mafrici A, Biraghi M, Cerri P, De Biase AM. Effectiveness of calcium antagonist drugs in patients with unstable angina and proven coronary artery disease. Eur Heart J 1988;9(suppl N):158-163.
14. Johnson SM, Mauritson DR, Willerson JT, Hillis LD. A controlled trial of verapamil for Prinzmetal’s variant angina. N Engl J Med 1981;304:862-866.
15. Parodi O, Simonetti I, Michelassi C, Carpeggiani C, Biagini A, L’Abbate A, Maseri A. Comparison of verapamil and propranolol therapy for angina at rest: a randomized, multiple crossover, controlled trial in the coronary care unit. Am J Cardiol 1986;57:899-906.
16. Woelfel A, Foster JR, McAllister RG, Simpson RJ, Gettes LS. Efficacy of verapamil in exercise-induced ventricular tachycardia. Am J Cardiol 1985;56: 292-297.
17. Gülker H, Godejohann U, Dorsel T, Behrenbeck T, Heuer H, Bender F. Prophylaxe belastungsinduzierter ventrikulärer Arrhythmien durch Verapamil. Z Kardial 1987;76:404-410.
18. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-392.
19. The Israeli Sprint Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J 1988;9:354-364.
20. Packer M. Combined beta-adrenergic and calcium-entry blockade in angina pectoris. N Engl J Med 1989;320:709-718.
21. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J 1989:299:1187-1192.
22. SPRINT Study Group. The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) II: design and methods: results (abstr). Eur Heart J 1988:9(suppl 1):350.
23. deGeest H, Kesteloot H, Piessens J. Secondary prevention of ischaemic heart disease: a long-term controlled lidoflazine study. Acta Cardiol 1979;34(suppl 24):7-50.
24. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 1988:2088-2093.